The Citizens Foundation (TCF) and Khan Academy Pakistan have launched a groundbreaking AI-powered initiative aimed at enhancing classroom learning in select TCF schools. This pilot programme ...
The European Medicines Agency (EMA) offered a positive opinion last week on a new artificial intelligence (AI)–based tool that supports pathologists in diagnosing and assessing the severity of ...
MASH and MASLD are prevalent, complex diseases often accompanied by metabolic comorbidities like obesity and diabetes. GLP-1 receptor agonists, such as semaglutide, show promise in resolving NASH ...
Inclusion of female and Hispanic/Latino patients has increased over time, but most trials of metabolic dysfunction-associated steatohepatitis (MASH) still take place in high-income countries and ...
NPR's Up First is the news you need to start your day. The three biggest stories of the day, with reporting and analysis from NPR News — in 10 minutes. Available weekdays at 6:30 a.m. ET, with ...
Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...
A powerful call to action, Bob Marley’s ‘Get Up, Stand Up’ continues to resonate with those struggling to overcome oppression. There’s a reason why The Wailers’ “Get Up, Stand Up ...
Found the Volkswagen Up of your dreams? Now you want to know all about it! With the help of Parkers, you can find out all of the key specs about the Volkswagen Up from fuel efficiency in MPG and top ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback